Leigh's Disease: The Acute Clinical Course of a Two-Year-Old Child with Subacute Necrotizing Encephalomyelopathy by Zinka, Bettina et al.
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2010, Article ID 986302, 3 pages
doi:10.1155/2010/986302
Case Report
Leigh’s Disease: The Acute Clinical Course of a Two-Year-Old
Child with Subacute Necrotizing Encephalomyelopathy
Bettina Zinka, Andreas Buettner, and Matthias Graw
Institute of Legal Medicine, University of Munich, Nussbaumstraße 26, 80336 Munich, Germany
Correspondence should be addressed to Bettina Zinka, bettina.zinka@med.uni-muenchen.de
Received 4 January 2010; Accepted 7 April 2010
Academic Editor: Mamede de Carvalho
Copyright © 2010 Bettina Zinka et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We report the untypical clinical course of a previously healthy two-year-old girl, who died suddenly and unexpectedly after an
episode of vomiting. At forensic autopsy no other pathological findings could be diagnosed than multiple reddish, sunken areas
in brain stem, mesencephalon, and pons. Histologically they presented as areas of spongiosis of the neuropil with prominent
endothelial hyperplasia and vascular proliferation whereas nerve cells were well preserved. On the basis of the characteristic
neuropathological findings in combination with the age of the child, we had to take into consideration that the child might have
died from subacute necrotizing encephalomyelopathy (Leigh’s Disease) despite the untypical, fulminant clinical course.
1. Introduction
Normally subacute necrotizing encephalomyelopathy
presents with a clinical course of at least several months
and impressive clinical signs. But possibly there are
undocumented, unexpected deaths which could have been
diagnosed as subacute necrotizing encephalopathy only in
postmortem examiniation, if performed, due to atypical
progression.
2. Case Report
A previously healthy 24-month-old girl with strabismus
concomitans, associated with a nystagmus, presented to a
pediatric hospital. Furthermore the girl’s mother reported
unspecific symptoms like attention deficits, decrease in
alertness, increased nervousness and “interaction problems”.
On examination the girl was found to be in general
good health with appropriate nutrition. Physical and psy-
chomotor development was documented to be normal.
Clinical examinations, including laboratory examinations as
well as a neurological examination with magnetic resonance
imaging (MRI), which was performed as a precaution to
exclude an intracranial disease, were all found to be normal.
Electroencephalography showed a small decrease in alert-
ness associated with sharp-wave and theta rhythm activity.
Ophthalmologically a strabismus concomitans divergence
was diagnosed. The child was allowed to return home but
ophthalmologic follow-up was recommended.
Three months later the child started vomiting at home.
Finally the paramedics were called as the girl lost hemor-
rhagic mucus from her nose. Shortly afterwards she lost
consciousness and when the paramedics arrived she was
already clinically dead. Reanimation was unsuccessful. Death
was attributed to aspiration during an assumed epileptic
seizure.
Forensic postmortem examination of the girl showed few
irregularities; in particular the heart and lungs were free
of any pathological findings. Laboratory examinations of
glucose metabolism as well as chemical-toxicological studies
showed normal results except for increased lactate concen-
tration in blood (47.9mmol/l; refernce: <2.4mmol/l) and
cerebrospinal fluid (26.3mmol/l; reference: 1.1–2.1mmol/l).
The brain weighted 1061 g. Leptomeninges and gyration
patterns were unremarkable; marked signs of edema and
significant tonsillar herniation were seen. However, on
horizontal sections small reddish foci of tissue softening with
cystic appearance were seen within the pons, mesencephalon,
and medulla oblongata (Figures 1 and 2).
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Figure 1: Reddish, sunken foci within the pons.
Figure 2: Cystic, reddish areas in mesencephalon, pons, and
medulla oblongata.
After fixation the brain was histologically examined
(hematoxylin and eosin, cresyl-violet, Luxol-Fast-Blue, van-
Gieson Elastica, PAS, and Prussian Blue).
Deparaffinized 5-µm-thick sections were immunostained
with the ABC method. For labelling astrocytes a mono-
clonal antibody against glial fibrillary acidic protein (GFAP,
dilution 1:100, DAKO, Germany) was used; for microglia a
monoclonal antibody against the HLA-DP, DQ, DR antigen
(CR 3/43, dilution 1:100, DAKO, Germany, predigestion
with formic acid) was used. Antigens were detected with a
Histostain-Plus Peroxidase Kit (Zytomed, Germany).
On histological examination there was widespread
hypoxic-ischemic nerve cell damage within the major lobes,
dentate nucleus, and Purkinje cell layer. On sections of the
caudate nuclei, thalamus, hypothalamus, mesencephalon,
pons, and medulla oblongata there were widespread foci of
spongiosis of the neuropil with prominent endothelial hyper-
plasia and vascular proliferation. Besides hypoxic-ischemic
changes, the nerve cells were relatively well preserved
(Figure 3). Immunostaining for GFAP revealed marked
astrogliosis. The white matter of the cerebral hemispheres,
the hippocampal formation, the medulla oblongata, and the
mamillary bodies were unremarkable.
3. Discussion
The rare subacute necrotizing encephalomyelopathy was first
described by Leigh [1] as a clinically and etiologically highly
variable, progressive syndrome seen particularly in pediatric
Figure 3: Histological picture of the macroscopic lesion of the pons
(HE, 100-fold).
population although a few juvenile and adult cases are known
[2, 3].
The unspecific, heterogenic, and apparently age-
dependent variation in clinical symptoms and course may
possibly be attributed to identification of different enzyme
defects in this disease. Already mitochondrial as well as
nuclear DNA enzyme defects have been found [2, 4, 5] that
determine similar clinical courses but occur at different ages.
Clinical symptoms are also determined by which area of the
brain is affected.
The infantile form usually begins during the first two
years of life with unspecific symptoms and a slowing in
psychomotor development. Other symptoms include atten-
tion deficit, limb hypotonia, visual irregularities including
nystagmus, poor strength, emesis, unwillingness to eat,
and loss of weight [2, 4, 6]. Neurological symptoms such
as ataxia, deficits of the pyramidal tract, apraxia, and
myoclonus often develop, followed by ophthalmoplegia and
respiratory difficulties as a sign of brain stem damage [2].
Congenital cytochrome-c-oxidase deficiency, pyruvate-
dehydrogenase deficiency as well as biotinidase deficiency are
known to cause these clinical symptoms [4, 7, 8]. These states
probably have an autosomal-recessive inheritance although
mitochondrial and maternal inheritance are being discussed
and sporadic cases are known [3, 4]. Genetic irregularities
could only be found in approximately 50% of all patients,
showing that there are many other biochemical irregularities
which could lead to the clinical syndrome of Leigh’s disease
[8].
Specific biochemical tests are still lacking, however
lactate acidosis and increased lactate-pyruvate quotient in
plasma and CSF are nearly always found [4]. The search
for mitochondrial DNA mutations as a common cause for
Leigh’s Disease and biochemical investigation of muscle
biopsies still remain the gold standard in diagnosis [9, 10].
On neuropathological examination of the brain symmet-
rical, central lesions of red brown colour in areas of the brain
stem, putamen, basal ganglia, thalamus, and posterior horn
of the spinal cord can macroscopically be identified [6].
In early stage neuropil is damaged by spongiosis, fol-
lowed by capillary proliferation, astrogliosis, and increased
numbers of macrophages. In the course of the disease
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demyelination occurs, which leaves neurons and axons
nearly intact. That allows, for example, differentiation from
ischemic/hypoxic lesions [1, 2, 6, 7]. In particular the
mesencephalon, pons, caudate, medulla oblongata, central
cranial nerve nuclei, inferior olivary nuclei, cerebellum, basal
ganglia, and the optic nerve are affected [6].
Destruction of cerebral tissue causes progressive neuro-
logical dysfunction, which regularly ends in death at about
two years after diagnosis due to central respiratory paralysis.
Currently there exists no curative therapy [3, 4, 6].
MRI shows symmetrical, hypodense (T1) and hyper-
dense (T2) lesions in the basal ganglia, involving especially
the area of the caudate and putamen. Similar lesions
are also seen in Wernicke’s encephalopathy, multiple scle-
rosis, Wilson’s disease, amino acid urea, mitochondrial
encephalomyelopathies, and various forms of intoxication
[3]. In contrast to Wernicke’s encephalopathy mamillary
bodies are spared from pathological changes [3]. A differ-
entiation to Wilson’s disease is possible through laboratory
studies of the blood [4].
At the moment most symptomatic therapies try to
improve the oxidative and bioenergetic capabilities of the
mitochondria [6]. The use of coenzyme Q10, thiamine, and
carnitine may cause a decrease in severity of symptoms in
a few cases [6]. Cacic et al. report that a 19-year-old man
symptoms were kept stable for at least four years by a therapy
including levodopa, carbidopa, and creatinine monohydrate
[8].
4. Conclusions
In the presented case the diagnosis of Leigh’s Disease
could only be reached postmortem although three months
prior to death MRI scans and laboratory examinations had
been performed. They showed normal findings, furthermore
other typical symptoms—like delay in psychomotor devel-
opment, weakness, eating difficulty, or typical neurological
symptoms—were not observed. The clinical symptoms on
the day of death were probably primarily of acute cerebral
origin. However, postmortem examination showedmorpho-
logical findings of the child’s brain which are specific to
Leigh’s disease. An increased lactate concentration in blood
and CSF could be confirmed in postmortem examination,
which is typical to Leigh’s disease, but can be seen in
many autopsies because of the generalized agonal cellular
hypoxemia.
It is to be assumed that this case report describes an
unusual, “acute” course of the normally subacute necrotizing
encephalomyelopathy with a strikingly short and mostly
unnoticeable clinical course.
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